Stephen C. Mathai

Johns Hopkins University — United States

Medicine · Health Sciences

54h-index11.4kcitations381works5.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pulmonary Hypertension Research and Treatments(298), Systemic Sclerosis and Related Diseases(99), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis(78), Cardiovascular Function and Risk Factors(75), Vascular Anomalies and Treatments(26)

Publications381 total

Risk Averse: Assessing Risk as a Surrogate Measure in Pulmonary Arterial Hypertension
American Journal of Respiratory and Critical Care Medicine·2026
Prevalence and Clinical Implications of Excess Adiposity in Group 1 Pulmonary Hypertension
Circulation Heart Failure·2025
Treatment Patterns in Patients With Incident Pulmonary Hypertension
CHEST Journal·2025
TEAM Sarcoidosis
CHEST Journal·2025
Disproportionate impairment in diffusing capacity predicts pulmonary hypertension with an elevated pulmonary vascular resistance in COPD
Thorax·2025
Multi-beat pressure–volume loop-derived right ventricular–pulmonary arterial coupling predicts transplant-free survival in pulmonary arterial hypertension
European Respiratory Journal·2025· 1 cited
Abstract 4366623: Metabolomics of Right Ventricular Systolic Function Across the Spectrum of Pulmonary Hypertension – insights from the PVDOMICS Cohort
Circulation·2025
Abstract 4363694: Time Trends and Demographic Disparities in Pulmonary Hypertension-Related Mortality in the United States, 2003–2023
Circulation·2025
Abstract 4364326: Right Atrial Longitudinal Strain Phenotypes in Patients with Systemic Sclerosis
Circulation·2025
Abstract 4364054: Prevalence and Clinical Correlates of Valvular Abnormalities in Systemic Sclerosis: Associations with Pulmonary Vascular and Disease Severity
Circulation·2025
Abstract 4364753: Refining Atherosclerotic Risk Prediction in Patients with Systemic Sclerosis: Association with Uric Acid and the Creation of a Novel Scleroderma-Atherosclerotic Cardiovascular Disease Risk (ScleroRisk) Assessment Model
Circulation·2025
Initial Evaluation of Pulmonary Hypertension Functional Classification Self-Report Measurement Properties
CHEST Journal·2025Open Access
CHARACTERISTICS AND PATTERNS OF FORCED VITAL CAPACITY TESTING IN REAL-WORLD SETTINGS AMONG PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
CHEST Journal·2025Open Access
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL EVALUATING THE SAFETY, TOLERABILITY, AND PHARMACODYNAMICS OF SARACATINIB IN IDIOPATHIC PULMONARY FIBROSIS
CHEST Journal·2025
Late Breaking Abstract - Sarcoidosis Pulmonary Function Phenotypes Associated with Quality of Life
2025
Increased Xanthine Oxidoreductase Activity in Patients With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
CHEST Pulmonary·2025Open Access
Advanced Echocardiographic Assessment Predicts 1-Year Mortality in Critically Ill Patients With Pulmonary Arterial Hypertension
JACC Advances·2025· 1 citedOpen Access
Refining Risk Prediction in Systemic Sclerosis–Associated Pulmonary Arterial Hypertension
Journal of the American Society of Echocardiography·2025· 1 cited
Lung Single-Cell Transcriptomics Reveal Diverging Pathobiology and Opportunities for Precision Targeting in Scleroderma-Associated Versus Idiopathic Pulmonary Arterial Hypertension
Circulation Genomic and Precision Medicine·2025· 1 citedOpen Access
Ground-Glass Opacities in Pulmonary Arterial Hypertension—Results from the PVDOMICS Study
Annals of the American Thoracic Society·2025· 1 citedOpen Access
page 1 of 20Next →

Frequent Co-authors

Paul M. Hassoun(36), Reda E. Girgis(21), Ryan J. Tedford(12), Ari Zaiman(12), Laura K. Hummers(11), Todd M. Kolb(10), Anna R. Hemnes(9), Hunter C. Champion(9), Fredrick M. Wigley(9), Noah Lechtzin(9), Rachel L. Damico(9), David A. Kass(8), Danielle Boyce(8), Traci Housten-Harris(7), Paul R. Forfia(6), Micah R. Fisher(6), Traci Housten(6), Barry A. Borlaug(5), Steven M. Kawut(5), Jérôme Le Pavec(5)